Improving Phenotype in Mice with Metachromatic Leukodystrophy
Author Information
Author(s): Franken S, Wittke D, Mansson JE, D'Hooge R, De Deyn PP, Lüllmann-Rauch R, Matzner U, Gieselmann V
Primary Institution: Department of Physiological Chemistry, University of Bonn, Germany
Hypothesis
Can reducing galactosylceramide and sulfatide synthesis improve the pathology in ASA-deficient mice?
Conclusion
The reduction of galactosylceramide and sulfatide biosynthesis leads to modest improvements in pathology in ASA-deficient mice.
Supporting Evidence
- The study showed no significant decrease in sulfatide storage in ASA-deficient mice with a CGT heterozygous background.
- Neuronal degeneration in the inner ear was decreased in ASA-deficient mice with one intact CGT gene.
- Behavioural tests indicated small improvements in certain areas for ASA-deficient CGT-heterozygous mice.
Takeaway
Scientists wanted to see if changing a gene in mice could help them feel better. They found that it helped a little bit, but not enough.
Methodology
Mice were bred to have a deficiency in arylsulfatase A and a heterozygous allele of UDP-galactose:ceramide-galactosyltransferase, and various tests were conducted to assess lipid levels and neuronal degeneration.
Limitations
The improvements observed were minor and may not translate to significant clinical benefits.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website